Mindbloom

Psychedelic medicine is here

New York, United States · Founded 2018 · $2.0M raised

Headquarters
New York, New York
Employees
201–500
Founded
2018
Business Model
B2C
Total Funding
$2.0M
Last Round
$2.0M SeedJan 2021
Rounds
1

About

Mindbloom is the largest national provider of at-home ketamine therapy for depression, anxiety, and PTSD. Founded in 2018, the company combines clinician-prescribed medicine with 1:1 coaching, group integration circles, and live support. Over 10,000 clients have participated in peer-reviewed clinical studies, with 89% reporting improvement in symptoms.

Summary

Mindbloom is a Digital Health company based in New York, United States, founded in 2018. It has raised $2.0M in total across 1 round, most recently a $2.0M Seed round in Jan 2021. Investors include Long Journey Ventures.

Tech & App Stack

9 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedJan 2021
$2.0M

Investors

Similar Companies